APA (7th ed.) Citation

Su, T. ‐. H., Hu, T. ‐. H., Chen, C. ‐. Y., Huang, Y. ‐. H., Chuang, W. ‐. L., Lin, C. ‐. C., . . . Hsieh, T. ‐. Y. (2016). Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. Liver International, 36(12), 1755. https://doi.org/10.1111/liv.13253

Chicago Style (17th ed.) Citation

Su, Tung ‐ Hung, et al. "Four-year Entecavir Therapy Reduces Hepatocellular Carcinoma, Cirrhotic Events and Mortality in Chronic Hepatitis B Patients." Liver International 36, no. 12 (2016): 1755. https://doi.org/10.1111/liv.13253.

MLA (9th ed.) Citation

Su, Tung ‐ Hung, et al. "Four-year Entecavir Therapy Reduces Hepatocellular Carcinoma, Cirrhotic Events and Mortality in Chronic Hepatitis B Patients." Liver International, vol. 36, no. 12, 2016, p. 1755, https://doi.org/10.1111/liv.13253.